Viatris Inc.

NASDAQ:VTRS

Drug Manufacturers - Specialty & Generic

Healthcare
$20.28 -2.29%

-$0.36 today

Market cap
$23.25B
Beta
0.90
P/E (TTM)
-59.9
EPS (TTM)
-$0.26
Dividend yield
3.12%
52W Low $8.63High $17.53

Volume 13.21M

Average 10.58M

VTRS Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Viatris Inc.NASDAQ: VTRS

Weighted Avg Shares · Q2 FY2026 · quarter ended Jun 2026

Weighted avg shares declines year over year

Q2 FY2026 weighted avg shares of 1.16B shares fell 0.8% year over year, ahead of the -2.4% change in trailing-twelve-month weighted avg shares. Sequentially, it rose 0.7% from the prior quarter. Over 3 fiscal years it compounded at -1.2% a year.

Context

  • Weighted avg shares increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of -0.8% holds above the trailing-twelve-month pace of -2.4%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
1.16B+0.7% QoQ
Last fiscal yearDec 2025
1.17B-1.9% YoY
LTMJun 2026
1.16B-2.4% YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-0.8%——
1 year-1.9%——
3-year CAGR-1.2%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
1.17B USD
Year-over-year change
-1.9%
4-year CAGR
-0.8%

Weighted Avg Shares vs competitors

How VTRS compares with its peers on the latest reported figures

  • VTRS's LTM Jun 2026 weighted avg shares of 1.16B shares is the 2nd highest of the 10 companies compared; the peer median is 315.69M shares.
  • Its year-over-year change of -2.4% is the 8th highest of 9, against a peer median of +1.2%.
  • Over three fiscal years its annual growth of -1.2% compares with a peer median of +0.7%.
VTRS Competitors Peer median
Weighted Avg Shares for VTRS and competitors
Company Period LTM YoY 3-year CAGR
HLNHaleon plcLTM Jun 20254.56B —-1.0%
VTRSViatris Inc.LTM Jun 20261.16B -2.4%-1.2%
TEVATeva Pharmaceutical Industries LimitedLTM Jun 20261.15B +1.5%+1.2%
RDYDr. Reddy's Laboratories LimitedLTM Sep 2026833.5M +0.1%+0.1%
BHCBausch Health Companies Inc.LTM Jun 2026372.41M +0.6%+0.8%
AMRXAmneal Pharmaceuticals, Inc.LTM Jun 2026315.69M +1.5%+27.6%
OGNOrganon & Co.LTM Sep 2026261.44M +1.0%+0.7%
ALKSAlkermes plcLTM Sep 2026166.35M +1.5%+0.2%
AMPHAmphastar Pharmaceuticals, Inc.LTM Mar 202646.16M -4.6%-1.3%
ANIPANI Pharmaceuticals, Inc.LTM Mar 202620.22M +4.0%+7.2%
Peer median (excluding VTRS) 315.69M+1.2%+0.7%

Competitors are the stored peer set for VTRS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue17.89B16.26B15.43B14.74B14.3B
Cost of Revenue12.31B9.77B8.99B9.12B9.29B
Gross Profit5.58B6.5B6.44B5.62B5.01B
Gross Margin31.2%40.0%41.7%38.2%35.1%
Research & Development681M662.2M805.2M808.7M965.9M
Selling, General & Admin4.53B4.18B4.65B4.43B3.79B
Operating Expenses5.61B4.88B5.67B5.61B7.68B
Depreciation & Amortization4.51B3.03B2.74B2.71B2.8B
EBITDA4.48B6.43B3.52B2.64B(395.4M)
EBITDA Margin25.0%39.6%22.8%17.9%-2.8%
Operating Income(34M)1.61B766.2M10.1M(2.66B)
Operating Margin-0.2%9.9%5.0%0.1%-18.6%
Interest Income00000
Interest Expense636.2M592.4M573.1M550M471.3M
Other Income / Expenses(630.4M)1.2B(563.3M)(633.3M)(1B)
Income Before Tax(664.4M)2.81B202.9M(623.2M)(3.67B)
Pre-Tax Margin-3.7%17.3%1.3%-4.2%-25.6%
Income Tax Expense604.7M734.6M148.2M11M(150.1M)
Net Income(1.27B)2.08B54.7M(634.2M)(3.51B)
Net Margin-7.1%12.8%0.4%-4.3%-24.6%
EPS (Basic)(1.05)1.710.05(0.53)(3.00)
EPS (Diluted)(1.05)1.710.05(0.53)(3.00)
Weighted Avg Shares1.21B1.21B1.2B1.19B1.17B
Weighted Avg Shares (Diluted)1.21B1.22B1.21B1.19B1.17B

Viatris Inc.

NASDAQ:VTRS

Intrinsic Alpha fair value

Locked

Current Price

$20.28

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.